Roles of host defense lectin.s in innate immunity

宿主防御凝集素在先天免疫中的作用

基本信息

  • 批准号:
    13143204
  • 负责人:
  • 金额:
    $ 67.39万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2005
  • 项目状态:
    已结题

项目摘要

Among pattern-recognition molecules, mannose-binding lectin (MBL) and ficolin have a unique ability to activate complement through their association with MBL-associated serine proteases (MASPs). Upon the binding of MBL and ficolin to PAMPs on pathogens, the proenzyme forms of MASPs are converted to the active forms and in turn MASPs activate the complement.In the present study, three lineages of MASP-deficient mice were established, including MASP・/3-deficient, MASP-2/sMAP-deficient and MASP-null mice. MASP-null mice were the most susceptible to bacterial infection, owing to the complete deficiency in the lectin pathway. As comparing with kinetics of the lectin pathway among the three lineages of MASP-deficient mice, MASP-1 was found to be involved in a unique route of the lectin pathway, termed `MASP-1 route', that was in a MASP-2-independent and C4-independent manner. By phenotype analysis of MASP-2/sMAP-deficient mice and its reconstitution with recombinant proteins, sMAP was demons … More trated to be a regulator of the lectin pathway, in which sMAP competitively inhibits the binding of MASP-2 to MBL.To define the role of ficolin in vivo, a lineage of ficolin A-deficient (FcnA^<-/->) mice was generated, which lacked ficolin A-based lectin complement pathway owing to the absence of ficolin A/MASPs complex in the serum. The defense activity of ficolin A-deficient mice against bacteria was significantly reduced, when it was assessed by bacterial growth inhibition in the blood. These results suggest that the lectin pathway is a highly sophisticated host defense system, consisting of two recognition molecules, three serine proteases and a regulator.In our phylogenetic approaches, the lectin pathway was identified in lamprey (a cyclostome belonging to the most primitive vertebrate) and ascidian (one of the most closest relatives to vertebrates), which lack the acquired immunity. This suggests that the lectin pathway has an ancient origin traced back to at least ascidians, and that it is crucial for innate immune defense in a wide animal world from the ascidians to mammals. Less
在模式识别分子中,甘露糖结合凝集素 (MBL) 和 ficolin 具有通过与 MBL 相关丝氨酸蛋白酶 (MASP) 结合而激活补体的独特能力。当 MBL 和 ficolin 与病原体上的 PAMP 结合时,会形成酶原。的 MASP 转化为活性形式,进而 MASP 激活补体。在本研究中,建立了三个 MASP 缺陷小鼠谱系,包括与凝集素途径的动力学相比,MASP·/3缺陷型、MASP-2/sMAP缺陷型和MASP缺失型小鼠最容易受到细菌感染。在 MASP 缺陷小鼠的三个谱系中,发现 MASP-1 参与凝集素途径的一种独特途径,称为“MASP-1 途径”,即通过对 MASP-2/sMAP 缺陷小鼠的表型分析及其用重组蛋白的重建,sMAP 被认为是凝集素途径的调节剂,其中 sMAP 竞争性抑制。 MASP-2 与 MBL 的结合。定义 ficolin 在体内的作用,ficolin A 缺陷谱系 (FcnA^</-/->)产生了由于血清中缺乏 ficolin A/MASP 复合物而缺乏基于 ficolin A 的凝集素补体途径的小鼠。通过细菌生长抑制来评估,ficolin A 缺陷小鼠对细菌的防御活性显着降低。这些结果表明,凝集素途径是一个高度复杂的宿主防御系统,由两个识别分子、三个丝氨酸蛋白酶和一个调节因子组成。在我们的系统发育方法中,在七鳃鳗中鉴定了凝集素途径。 (属于最原始脊椎动物的环口动物)和海鞘(与脊椎动物最接近的亲戚之一)缺乏获得性免疫力,这表明凝集素途径的古老起源至少可以追溯到海鞘,并且它至关重要。用于从海鞘到哺乳动物的广泛动物世界的先天免疫防御。

项目成果

期刊论文数量(402)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kakinuma Y.et al.: "Molecular cloning and characterization of novel ficolins from Xenopus leavis."Immunogenetics.. 55(1). 29-37 (2003)
Kakinuma Y.等人:“非洲爪蟾新型纤维蛋白的分子克隆和表征。”免疫遗传学.. 55(1)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Association between mannose-binding lectin levels and graft survival in kindey transplantation.
甘露糖结合凝集素水平与肾移植中移植物存活之间的关联。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Berger;S;P. et al.
  • 通讯作者:
    P. et al.
Human M-ficolin is a sevretory protein that activates the lectin complement pathway.
人 M-ficolin 是一种激活凝集素补体途径的严重蛋白。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Liu;Y.et al.
  • 通讯作者:
    Y.et al.
Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRLrFasL(gld) mice are under the control of the MRL genetic background.
MRL-Fas(lpr) 或 MRLrFasL(gld) 小鼠中的异常 IgG 半乳糖基化和关节炎受 MRL 遗传背景的控制。
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kuroda;Y. et al.
  • 通讯作者:
    Y. et al.
Characterization of the Xenopus galectin family. Three structurally different types as in mummals and regulated expression during embryogenesis.
非洲爪蟾半乳糖凝集素家族的表征。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shoji;H. et al.
  • 通讯作者:
    H. et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJITA Teizo其他文献

FUJITA Teizo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJITA Teizo', 18)}}的其他基金

The lectin complement pathway is involved in activation of the alternative pathway
凝集素补体途径参与旁路途径的激活
  • 批准号:
    21390086
  • 财政年份:
    2009
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular basis of complement activation by ficolins throu the lectin pathsay
纤维胶蛋白通过凝集素途径激活补体的分子基础
  • 批准号:
    12470079
  • 财政年份:
    2000
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
  • 批准号:
    07044285
  • 财政年份:
    1995
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
A NOVEL LECTIN-DEPENDENT ACTIVATION PATHWAY OF COMPLEMENT
一种新型的凝集素依赖性补体激活途径
  • 批准号:
    06454223
  • 财政年份:
    1994
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
  • 批准号:
    06044189
  • 财政年份:
    1994
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Production of chimeric protein to scavenge immune complexes
产生嵌合蛋白以清除免疫复合物
  • 批准号:
    02557026
  • 财政年份:
    1990
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似国自然基金

补体凝集素途径激活导致IgA肾病肾脏微血管病变的机制研究
  • 批准号:
    82170710
  • 批准年份:
    2021
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
IgA1分子N-糖链诱导凝集素途径补体激活在IgA肾病发病中的作用和机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
C型凝集素样受体CLEC-2通过旁分泌信号途径调控胃癌干细胞niche以及化疗抵抗的功能机制研究
  • 批准号:
    31870800
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目
三疣梭子蟹补体凝集素激活途径及其介导的母源免疫机制研究
  • 批准号:
    41776159
  • 批准年份:
    2017
  • 资助金额:
    71.0 万元
  • 项目类别:
    面上项目
LOX-1/Cullin7介导的泛素化修饰在脂肪细胞胰岛素抵抗中的作用及机制研究
  • 批准号:
    81603171
  • 批准年份:
    2016
  • 资助金额:
    17.3 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

MASP-2 Antibodies for Diabetic Neuropathy
用于糖尿病神经病变的 MASP-2 抗体
  • 批准号:
    8393195
  • 财政年份:
    2012
  • 资助金额:
    $ 67.39万
  • 项目类别:
Development of MASP-2 MoAbs for the treatment of diabetic nephropathy
开发用于治疗糖尿病肾病的 MASP-2 MoAb
  • 批准号:
    8007238
  • 财政年份:
    2010
  • 资助金额:
    $ 67.39万
  • 项目类别:
The lectin complement pathway is involved in activation of the alternative pathway
凝集素补体途径参与旁路途径的激活
  • 批准号:
    21390086
  • 财政年份:
    2009
  • 资助金额:
    $ 67.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
MASP-2: A Potential New Target for Treatment of Rheumatoid Arthritis
MASP-2:治疗类风湿关节炎的潜在新靶点
  • 批准号:
    7392873
  • 财政年份:
    2008
  • 资助金额:
    $ 67.39万
  • 项目类别:
MASP-2 Therapy for Macular Degeneration
MASP-2 治疗黄斑变性
  • 批准号:
    7218775
  • 财政年份:
    2007
  • 资助金额:
    $ 67.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了